510(k) Report

510(k) · Cleared

Cleared

MODI System

K260062510(k) TraditionalCleared Sep 8, 2026243-day reviewClass II21 CFR 862.1358

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DreaMed Diabetes, Ltd. · QRX Continuous Glucose Monitor Informed Insulin Dose Calculator

Cleared on Sep 8, 2026 as substantially equivalent to K252818 (Dexcom, Inc., 2025) after a 243-day review. Its family tree reaches back 6 generations to 2018.

Decided
Sep 8, 2026
Review
243 days
Class
Class II
Product code
QRX
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to DEN170043 (2018). No later device cites it as a predicate yet.

  1. Root · 6 generations backDEN170043 DreaMed Advisor ProDreaMed Diabetes, Ltd. · 2018
  2. 5 generations backK191370 DreaMed Advisor ProDreaMed Diabetes, Ltd. · 2019
  3. 4 generations backK201476 DreaMed Advisor ProDreaMed Diabetes, Ltd. · 2020
  4. 3 generations backK203772 Omnipod 5 SmartBolus CalculatorInsulet Corporation · 2022
  5. 2 generations backK222888 BlueStar CGM insulin dose calculatorWelldoc, Inc. · 2023
  6. 1 generation backK252818 Dexcom Smart BasalDexcom, Inc. · 2025
  7. This deviceK260062 MODI SystemDreaMed Diabetes, Ltd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6DEN170043DreaMed Advisor ProDreaMed Diabetes, Ltd.2018—
−5K191370DreaMed Advisor ProDreaMed Diabetes, Ltd.2019—
−4K201476DreaMed Advisor ProDreaMed Diabetes, Ltd.2020—
−3K203772Omnipod 5 SmartBolus CalculatorInsulet Corporation2022—
−2K222888BlueStar CGM insulin dose calculatorWelldoc, Inc.2023—
−1K252818Dexcom Smart BasalDexcom, Inc.2025—
0 (this device)K260062MODI SystemDreaMed Diabetes, Ltd.2026—
FIG. 1 — Lineage of K260062, 2018–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QRX device

  1. #1 K252818 Dexcom Smart Basalscore 14.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K252818Dexcom Smart Basal
Summary page 5
…assification Class II, 21 CFR 862.1358, Product Code: QRX, Class II, 21 CFR 868.1890, Product Code: NDC. Predicate Devices DexCom Smart Basal K252818 Reference Device: DreaMed endo.digital platform (K232722)…
Dexcom, Inc.2025—
†K232722endo.digital PlatformDreaMed Diabetes, Ltd.2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 4 companies; a new generation was cleared every 1.4 years on median.
  • None of the 6 ancestors has a recall.

How does its category compare?

All QRX devices

QRX Continuous Glucose Monitor Informed Insulin Dose Calculator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · QRX

1in 2025

2022: 22023: 22025: 12026 (partial year): 1
2007high 2 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRX

Too few QRX 510(k)s in any year since 2007 to give a median.

Recalls per year · QRX

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QRX

1in 2022

2022: 1
2007high 1 (2022) · low 0 (2007)2025

MAUDE reports naming product code QRX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20222—01
20232—00
20240—00
20251—10
20261—0—

What is it indicated for?

MODI insulin dose calculator is software intended for the management of type 2 diabetes in persons aged 18 years and older requiring long-acting insulin with or without rapid-acting insulin injections. MODI insulin dose calculator calculates a dose of basal (long-acting) insulin with or without a dose of bolus (rapid-acting for meal and correction) insulin based on glucose measurements from an iCGM (Integrated Continuous Glucose Monitor) and insulin delivery data (i.e. time of dose with or without amount of dose). MODI insulin dose calculator intended for single patient, home use and requires a prescription by a healthcare provider.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K260062: MODI System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K260062

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026